Proliferation and survival of Schwann cells are important for nerve development and for disease processes in peripheral nerves. We have analyzed embryos lacking ␣4-or ␣5-integrins and show here that these integrins contribute to the control of glial cell numbers. To overcome early embryonic lethality an explant and grafting system that allows the study of isolated glial progenitor cells both in vitro and in vivo was used. Schwann cells differentiate in the absence of ␣5 but their numbers and the proliferation rate of early progenitor cells are reduced, suggesting that ␣5 is essential for normal proliferation. Survival, rather than proliferation, is compromised in ␣4-deficient explants. Conditional immortalization allowed further characterization and revealed that ␣4 contributes to survival in a cell-density-dependent fashion. In addition, transplants into chicken embryos were used to analyze in vivo cell migration and showed that cell death occurs mainly in highly motile, individually migrating cells. The cell death patterns in vitro and in vivo argue that ␣4-integrins play a role in survival during cell migration. Neural crest migration has been suggested to require these integrins; however, no defects in migration were observed in the absence of ␣4 or ␣5. We conclude that integrins can complement growth factors in the control of glial cell numbers.
INTRODUCTION
Schwann cells and melanocytes share the ability to migrate long distances and to proliferate extensively during embryogenesis and in the adult. Both cell types are prone to deregulated growth especially in Schwann cells, the predominant cell type in tumors of the peripheral nervous system. Growth regulation in Schwann cells has therefore been a major focus of study, leading to the identification of soluble mitogens and growth factor receptors important for proliferation and survival (reviewed in Jessen and Mirsky, 1999) . Recent studies in a number of cell types have shown that the extracellular matrix (ECM) is an equally important regulator of growth (reviewed in Schwartz and Baron, 1999) . Little is known about the contribution of extracellular matrix-derived signals to the growth and survival of Schwann cells.
Schwann cells, both of the myelinating and of the nonmyelinating type, satellite cells, and enteric glial cells are the sole glial cells of the peripheral nervous system. These glial cells are in large part derived from neural crest cells that migrate ventrally from the dorsal neural tube during embryogenesis, colonize the condensing ganglia, and form peripheral nerves. The molecular steps involved in the commitment of neural crest cells to the glial lineage are not well understood, although both bipotent glial/melanocyte and multipotent precursors have been described, and growth factors such as neuregulin have been shown to promote glial commitment (Le Douarin and Ziller, 1993; Shah et al., 1994) . The development of peripheral nerves involves a mutual dependence of Schwann cells and axons for their proliferation and survival (Davies, 1998; Riethmacher et al., 1997) . For example, Schwann cell precursors receive axonally derived ␤ forms of neuregulin that promote their survival and maturation into differentiated Schwann cells (Dong et al., 1995) . The number of Schwann cells in peripheral nerves is tightly regulated during development, and programmed cell death, in addition to proliferation control, is thought to be required to generate the final 1:1 ratio of Schwann cells to axons in mature nerves (Ciutat et al., 1996; Syroid et al., 1996; Trachtenberg and Thompson, 1996) . This has been confirmed in isolated intermediates of the Schwann cell lineage from rat (Jessen et al., 1994) and mouse embryos (Dong et al., 1999) , which each show distinct proliferation and survival characteristics in response to signaling factors such as neuregulin (reviewed in Jessen and Mirsky, 1999) . The contribution of cell-matrix interactions to the control of glial cell numbers is not well defined. However, growth-and survival-promoting effects of ECM molecules have long been recognized (Bunge et al., 1989) . For example, fibronectin (FN) is a favorable substrate for the migration and proliferation of Schwann cells in culture and promotes nerve regeneration when applied to acellular nerve grafts. Adhesion to the ECM is largely mediated by the integrin superfamily. Integrins are heterodimeric transmembrane glycoproteins that transduce signals from outside the cell and regulate cell growth and survival by activating intracellular signaling pathways similar to those of growth factors (reviewed in Giancotti and Ruoslahti, 1999; Hynes, 1992; Schwartz and Baron, 1999) . Integrins also serve important structural roles by linking ECM proteins with the actin cytoskeleton and are essential for cell migration and regulation of cell shape. Interestingly, these changes in cell shape and cytoskeletal tension are thought to be involved in the spatial regulation of cell growth (Huang and Ingber, 1999) . Thus integrins are essential for both cell motility and growth regulation and could be involved in the extensive migration and proliferation of Schwann cells.
The ␣5-integrin subunit associates exclusively with the ␤1 subunit and functions as a primary receptor for FN, whereas ␣4-integrins can engage in cell-cell and homophilic interactions, in addition to fibronectin binding. Targeted deletions in mice result in embryonic lethality and defects in extraembryonic and embryonic mesoderm (␣5-null; Yang et al., 1993) or placental and cardiac defects (␣4-null; Yang et al., 1995) . Expression-and functionperturbing studies have linked ␣4 and ␣5 to the regulation of cell migration. For example, ␣4-integrins have been shown to affect the migration of a variety of cell types in vitro (Beauvais et al., 1995; Mould et al., 1994; Wu et al., 1995) . Neural crest cells migrate extensively on FN and express many integrins including ␣4␤1, ␣5␤1, and at least six other ␤1-integrins (Testaz et al., 1999) . Neural crest migration can be blocked using antibodies and soluble peptides against ␤1 or ␣4 in vitro (Dufour et al., 1988) and at cranial and truncal levels in vivo (Bronner-Fraser, 1986; Kil et al., 1998) .
In the present study, we have examined neural crest development and differentiation in ␣4-and ␣5-deficient embryos. To circumvent early embryonic lethality in these embryos we made extensive use of neural explants. A modification of the explant culture made it possible to follow the differentiation of the glial lineage in culture. The association of glial cells with axonal fibers in explants and the development of neural crest cells into fully mature Schwann cells can be studied. We have also been able to conditionally immortalize progenitor cells of the glial lineage for further study in vitro and in vivo. We used these assays to investigate the role of integrins in proliferation, survival, and differentiation of the peripheral glial lineage. Finally, we employed an assay designed to follow the migratory behavior of cultured cells upon grafting into an in vivo environment. Using small grafts implanted into the neural crest pathway of the chicken embryo, it is feasible to analyze cell migration even when few cells are available, as is the case with ␣5-deficient cells. The grafted mouse cells migrate along the migratory pathway of the developing chicken embryo and contribute to peripheral ganglia and nerves. This system has allowed us to determine the migratory ability of ␣5-null crest cells and analyze an ␣4-dependent survival defect in vivo. We report here that integrins contribute to the development of the glial lineage by regulating survival and proliferation of glial progenitor cells.
MATERIALS AND METHODS

Media and Materials
Medium used to study emigration of cells from neural crest cell (NCC) explants (NCC-medium) consists of DMEM/F12 (Gibco), 10% FBS (Hyclone, Logan, UT), and antibiotics. To promote glial development, DMEM/F12 (Gibco), was supplemented with 10% chicken embryo extract, N2 and B27 supplements (GIBCO), bFGF (0.4 ng/ml; Upstate Biotechnology, Inc.), and antibiotics (glial proliferation medium). Differentiation medium is based on Stemple and Anderson (1992) and consists of DMEM/F12, 10% FBS, N2 and B27 supplements, bFGF (0.4 ng/ml), and forskolin (5 M; Sigma). Human plasma FN, vitronectin (VN), and mouse laminin (LN) were obtained from Becton-Dickinson. Embryos were derived from mouse lines carrying the ␣5-null or the ␣4-null mutation on a mixed genetic background of 129Sv and C57BL/6 (Yang et al., 1993 (Yang et al., , 1995 . Genotyping of embryos and mice was performed by PCR as previously described (Yang et al., 1993 (Yang et al., , 1995 . Immortomouse mice (H-2Kb-tsA58 transgenic, large T antigen (LTAg)-containing mice, see Jat et al., 1991) were obtained from Charles River Laboratories (Wilmington, MA).
Antibodies
Primary antibodies were monoclonal anti-neurofilament 160 (Sigma), AP-2 (Santa Cruz Biotechnology), GFAP (DAKO), nestin (Rat-401; Developmental Studies Hybridoma Bank), Po (a gift from J. J. Archelos, Karl-Franzens-Universitä t, Graz, Austria), and S100 (DAKO). Rabbit antisera against the cytoplasmic domains of the human ␤1 subunit and the chicken ␣3A subunit were prepared as described (Hynes et al., 1989; Marcantonio and Hynes, 1988) . Rabbit antiserum against the ␣5 subunit was kindly provided by Dr. C. Whittaker and antisera against ␤3 and ␣v integrin subunits were purchased from Chemicon International. Secondary antibodies conjugated with rhodamine or fluorescein (FITC) were used (Tago, Camarillo, CA).
Embryo Explants
Neural crest cells were isolated from embryos at day 8.5 (for ␣5) or day 9.0 (for ␣4) using a method based on that of Jaenisch (1985) . Concentration of dispase used for enzymatic tissue separation was modified to 0.04 U/ml in Ca 2ϩ , Mg 2ϩ -free PBS and embryos were treated at 4°C for 15 min and 37°C for 5-7 min. Fragments of the neural tube, corresponding to five to eight somites in length, were explanted in NCC-medium onto tissue culture dishes (Falcon) coated with fibronectin (10 g/ml). The extent of neural crest migration was estimated by determining the diameter of the explant (average of x and y axes). For each genotype, at least six embryos were analyzed from two litters or more.
To allow glial cells to develop from explanted neural crest cells, glial proliferation medium was used instead of NCC-medium. Medium was replaced every 3-4 days. Glial progenitor cells differentiate from neural crest cells in the halo around the explant. To study axonal-glial development in explants, large neural tube fragments, equivalent to 12 to 15 somites in length, were explanted in glial proliferation medium. Axons (labeled with NF160) grow out from the neural tissue under these conditions and associate with the glial cells (visualized with S100) that differentiate from neural crest cells.
Schwann Cell Differentiation
To assay for terminal Schwann cell differentiation, explants were cultured as described above in glial proliferation medium. After 3 days, the neuroepithelium was carefully removed and the remaining neural crest cells were replated onto culture plates coated serially with poly-D-lysine (pDL) and FN (10 g/ml). Cells were grown to subconfluency. Glial proliferation medium was replaced with differentiation medium and cells were cultured for at least another 14 days. Bipolar, highly elongated Schwann cells develop under these conditions. Terminal differentiation of Schwann cells was confirmed using immunofluorescence-staining of Po as a marker for myelin.
Whole-Mount Immunostaining
The immunohistochemistry protocol is based on Davis et al. (1991) with the following modifications. Embryos were fixed in 4% paraformaldehyde (for AP-2, nestin) or methanol:DMSO (4:1; for NF160, GFAP) overnight at 4°C. Primary antibodies were diluted 1:300 (1:3 for nestin) in PBSMT and secondary goat anti-rabbit or anti-mouse antibodies coupled with horseradish peroxidase (Jackson ImmunoResearch) were diluted 1:200 in PBSMT and 1% normal goat serum (Vector Laboratories). Incubation was done overnight at 4°C. Before the peroxidase reaction, an additional wash overnight at 4°C was added. Substrates for the peroxidase reaction were either diaminobenzidine at 0.25 mg/ml (for NF160) or Vector SG substrate (Vector Laboratories), prepared according to the manufacturers' instructions. Embryos were first incubated in PBT containing substrate for 40 min, followed by addition of fresh substrate and hydrogen peroxide, and the reaction was allowed to continue until appropriate staining was obtained (up to 40 min for SG substrate). Embryos were washed in PBT, dehydrated through a methanol series, and cleared in xylene. For sectioning, xylenecleared embryos were embedded in paraffin and sectioned at 10 m.
Immunofluorescence
Cells were plated on coverslips or eight-well glass slides (Nunc) coated with 10 g/ml human plasma FN. Fixation was done in methanol (5 min, Ϫ20°C; for cytoplasmic antigens), acid ethanol (NF160, GFAP), or 3.7% formalin for 10 min and permeabilization for 10 min in 0.3% Triton X-100. After blocking for 30 min in 10% normal goat serum in PBS, cells were stained with primary and secondary antibodies diluted in blocking buffer for 30 min at 37°C. FITC-and rhodamine-coupled secondary antibodies were used at 1:300. Representative fields were photographed on a Zeiss Axiophot microscope.
Immunoprecipitations and Immunoblotting
Pools of wt-glimorto and ␣4-glimorto cells were cultured under permissive conditions. Cells were replated at low density onto 15-cm dishes coated with 10 g/ml FN and cultured for 2 h. Surface biotinylation was carried out using the membrane-impermeable biotinylation reagent Sulfo-NHS-biotin (Pierce). Adherent cells were washed in cold PBS and 1 mM Ca 2ϩ and 1 mM Mg 2ϩ (PBS/Ca-Mg) and overlaid with 1 mg/ml sulfo-NHS-biotin in PBS/ Ca-Mg for 20 min. After washing the cells with PBS, the residual NHS groups were reacted with 0.1 M glycine/PBS for 15 min. All biotinylation and lysis steps were carried out on ice.
Immunoprecipitation and nonreducing SDS-PAGE were performed as described previously (DiPersio et al., 1997) . Briefly, after washing, cells were lysed in 2 ml of a detergent buffer containing 200 mM octyl-␤-D-glucopyranoside (Calbiochem), 50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , and protease inhibitor cocktail (complete; Roche Molecular Biochemicals). Lysates were spun for 10 min at 14,000g. Supernatants were preincubated with 100 l of protein A-Sepharose (1:1 slurry; Pharmacia LKB) for 1 h and the beads sedimented for 2 min at 10,000g. Equal amounts of protein (175 g) were immunoprecipitated with antiintegrin antibodies or rabbit IgG. Briefly, BSA was added to lysates to a final concentration of 3 mg/ml, followed by 5 l of antiserum. After incubation at 4°C for 1 h, 50 l of protein A-Sepharose (1:1 slurry preabsorbed with 10 mg/ml BSA in lysis buffer) was added to the lysates and incubated overnight at 4°C. Samples were washed six times with cold lysis buffer containing protease inhibitors. Samples were suspended in SDS-PAGE sample buffer, boiled for 5 min, and analyzed using nonreducing SDS-PAGE with 8% acrylamide and 3% stacking gels. The samples were electroblotted to nitrocellulose membranes. The membranes were probed with streptavidin-peroxidase (Amersham Life Sciences) at 1:10,000 and developed with enhanced chemiluminescence.
Immortalization of Glial Progenitor Cells
A temperature-sensitive LTAg (H-2K b -tsA58) was introduced into mouse lines carrying the ␣5 or ␣4 knockout mutations by breeding to Immortomouse (Jat et al., 1991) . The lines also contain the Rosa-26 locus, a lacZ-containing transgene introduced for marking purposes (Friedrich and Soriano, 1991) . The lacZ marker was not used further because glimorto cells were found to lose ␤-gal expression upon shift to restrictive culture conditions. Neural tubes were explanted as described above and neuroepithelial tissue was carefully removed after 48 h in culture. The remaining cells were replated onto 24-well dishes coated with FN (10 g/ml) and further expanded at medium cell density, taking care that cultures do not reach confluency. Permissive conditions of 33°C, 5% CO 2 and glial proliferation medium containing 80 U/ml mouse IFN-␥ (Genzyme Diagnostics) were used during the entire immortalization procedure. Clonal lines were established by seeding cells at a clonal density of 120 cells/10-cm plate and manual picking after 4 -6 days in culture. Twelve clones were isolated for each genotype using cells from early passages. They were expanded and tested for their ability to adopt a Schwann cell morphology when cultured under differentiation conditions.
Proliferation Assay
Neural tubes from wt and ␣5-null embryos, with and without the presence of LTAg, were explanted on FN/VN-coated dishes. The neural crest cells that migrated onto the culture dish were replated 3 to 4 days later at clonal density. FN (10 g/ml)-coated 10-cm dishes were used and the cells were cultured in glial proliferation medium for up to 2 weeks at 37°C or permissive conditions (for LTAg-containing cells). Individual clones were marked and the number of clones and approximate number of cells within were scored during the culture period.
Cell Death Determination
Apoptotic cells in vitro were detected using terminaltransferase-biotinylated-dUTP nick-end-labeling (TUNEL). Neural tubes were explanted on coverslips coated with 10 g/ml FN and cultured for 4 -5 days until ␣4-deficient cells began to be lost. The TUNEL reaction was carried out as described (Attardi et al., 1996) . Rhodamine-conjugated streptavidin was used to visualize TUNEL reaction products.
Cell death was analyzed in whole-mount chicken embryos using dye exclusion labeling with Nile blue sulfate (Serva, Heidelberg, Germany). First, fluorescent images of unprocessed embryos were taken using a CCD camera and a Zeiss Axiophot microscope equipped with epifluorescence optics to record the position of transplanted cells. Embryos were transferred into a prewarmed solution of 0.003% Nile blue sulfate in DMEM/F12, incubated for 20 -30 min at 37°C, and washed briefly in PBS and images were recorded within 30 min. Adobe PhotoShop was used to superimpose images of DiI-labeled and Nile blue-marked cells in some cases.
Chick/Mouse Chimera
Preparation of graft aggregates. Glimorto cell clones were used as grafting material for ␣4-null transplants. Cells were shifted to 39°C for 1-2 days and cultured in glial proliferation medium without IFN-␥ (restrictive conditions) or in some experiments directly from cells cultured under permissive conditions. Primary cells were used for ␣5-null grafts. The neural tube was removed from primary explants cultured on FN/VN after 2-3 days of culture and the neural crest replated onto FN/VN plates and allowed to proliferate for an additional 3 days in glial proliferation medium. The primary cells develop along the glial lineage under these conditions, but note that the cultures at this stage consist of a heterogeneous population of differentiation intermediates, including nonglial cell types. Cultured cells to be grafted were first labeled with Cell Tracker CM-DiI (Molecular Probes, Eugene, OR), an aldehyde-fixable lineage tracer. For efficient labeling in vitro, cells were briefly exposed to CM-DiI in an isotonic solution, omitting salts, to give strong and homogeneous staining. Cells were grown on FN-coated culture dishes until they reached near confluency. They were washed two times with PBS and rinsed briefly with 0.3 M sucrose in H 2 O. CM-DiI (10 g/ml) in 0.3 M sucrose was gently pipetted onto the cells and washed with PBS a few seconds later. All solutions were prewarmed to 37°C. Cells were cultured for another 12-18 h prior to grafting. Mouse cells were transplanted into chicken embryos as small cell aggregates of a few hundred cells. Small aggregates were obtained by scraping cells manually from the culture plate using tungsten needles. Cell aggregates were transferred into Tyrode's saline chilled to about 10°C and used for grafting within 2 h. Shortly before grafting, aggregates were visualized by adding 0.1% Nile blue sulfate at a final concentration of 0.0004%, which stains the cells light blue, just enough to be visible during grafting. After transplantation, some unused aggregates were transferred back into culture for viability testing.
Grafting procedure. Fertilized chicken eggs (Spafas, Preston, CT) were incubated for 2 days at 38°C in a humidified incubator. Embryos were prepared for grafting in ovo. A small volume of 0.01% Nile blue sulfate solution in Tyrode's saline was applied to enhance visibility of embryonic contours. A slit was made between neural tube and embryo at the level of the fifth last formed somite using a tungsten needle. Cell aggregates were transferred next to the graft site and moved into the slit such that the grafted cells come to lie at the dorsal margin between neural tube and somite. The graft-aggregate extends over roughly 60% of the somite, equally centered between rostral and caudal somite halves. For confirmation of cell number and graft position, some embryos were sectioned shortly after the grafting procedure. Grafted cells at comparable numbers were reproducibly found to occupy the dorsal space next to the neural tube positioned to enter both ventral and dorsal migratory pathways. Eggs were returned to the incubator and allowed to develop further for up to 6 days.
Processing of embryos. The positions of DiI-labeled cells were digitally recorded and the embryos fixed in 10% formalin for 6 to 14 h at 4°C. Embryos were washed several hours in PBS at 4°C and conventionally embedded in paraffin as soon as possible. All images were recorded using a CCD camera (Optronics, CA) and a Zeiss Axiophot microscope equipped with epifluorescence optics. To determine the number of grafted cells in dorsal root ganglia (DRG), DiI-labeled cells were counted in serial sections from three embryos each. Average and standard deviation were calculated.
RESULTS
PNS Development in ␣4-Null Embryos
We are interested in the role that FN receptors such as ␣4-and ␣5-integrins play in the migration of neural crest cells and their subsequent differentiation, particularly along the glial lineage. About 50% of the ␣4-null embryos survive sufficiently to allow trunk neural crest migration and the initial phase of glial development to be studied in vivo. These embryos develop to E11.5 before reduced viability due to a heart defect becomes apparent (Yang et al., 1995) . Embryos were stained immunohistochemically and sectioned serially for detailed analysis. The gross anatomy of the PNS was found to be normal in ␣4-null embryos stained for the neurofilament protein NF160 (Figs. 1A and 1B) . Ganglia of the cranial and trunk region, including DRG and chain ganglia, were present and peripheral nerve projections in wt embryos were indistinguishable from those in ␣4-null embryos. Major deficiencies in PNS development were not obvious in ␣4-null embryos, suggesting that most of the neural crest cells migrate successfully toward their targets and participate in PNS formation. To study further neural crest development we analyzed the transcription factor AP-2, which is widely expressed in neural crest cells during their migration and in derivatives such as Schwann cells. Migratory neural crest cells labeled with AP-2 are present in ␣4-null embryos, as shown here in lumbar sections at E10.5 adjacent to the neural tube (Figs. 1C and 1D ). At E11.5 AP-2-positive cells were observed along the peripheral nerves, including the ventral root, cranial and spinal nerves, and in many cells of the DRG in both ␣4-null and wt embryos (Figs. 1E and 1F) . To confirm the presence of Schwann cells, we analyzed the expression of nestin and GFAP, two markers strongly expressed in culture by glial progenitor cells (see below). While not as strong and widespread in expression at this stage as AP-2, many Schwann cells labeled with nestin (Figs. 1G and 1H) or GFAP were present along peripheral nerves in ␣4-null embryos and expression in ganglia and nerves was not noticeably different between null and wt embryos. Strong nestin signal was also seen in developing muscle cells as reported (Hockfield and McKay, 1985) . Thus, neural crest cells appear to migrate properly and form a peripheral nervous system with both neurons and glial cells in ␣4-deficient embryos.
␣4-Integrins Are Not Required for the Migration of Trunk Neural Crest Cells in Vitro
Studies using inhibitory antibodies against ␣4 have been shown to affect neural crest emigration in vitro and migratory patterns in vivo (Dufour et al., 1988; Kil et al., 1998) . The histology and expression of markers in ␣4-null embryos have not indicated defects in neural crest migration, but minor deficiencies cannot be excluded. To investigate the proposed requirement for ␣4 in neural crest migration we analyzed the emigration of neural crest cells from truncal explants of ␣4-null embryos (Fig. 2) . No defects in attachment of neural tubes to the FN substrate or emigration of crest cells from the explants were apparent in ␣4-null explants (Fig. 2B) . Furthermore, no statistically significant difference in the diameter of explants was observed between wt and ␣4-null explants during the culture period (Fig. 2C) . The integrin ␣4 subunit appears to be dispensable for neural crest migration in vitro.
The Survival of Glial Progenitor Cells Is Affected in ␣4-Null Explants
The integrin ␣4 subunit is expressed during development of the PNS in DRG and nerve projections, consistent with a role in glial development (Sheppard et al., 1994) . To investigate development of peripheral glial cells in the integrindeficient embryos we made use of a glial explant system. The differentiation of glial cells can be followed in longterm cultures under conditions promoting glial differentiation; either directly in explants of neural tubes or using FIG. 1. Development of the peripheral nervous system analyzed in whole-mount embryos. (A, B) Ganglia and nerves are visualized in whole-mount embryos using neurofilament staining. Dorsal root ganglia, chain ganglia, enteric ganglia, as well as the peripheral nerve projections visible at this stage in wt embryos (A), are all present in null embryos (B). Sections of wt (C, E, G) and ␣4-null embryos (D, F, H). Embryos were stained for AP-2 at E10.5 (C, D) and E11.5 (E, F) or nestin (G, H; E11.5) and then sectioned. Neural crest cells are marked by AP-2 during their migration (C, D). In addition, AP-2 and nestin are expressed in cells of the DRG and in Schwann cells lining the peripheral nerves. No difference in the patterns of AP-2 and nestin were seen in ␣4-null compared with wt embryos. Black arrows point to Schwann cells located next to peripheral nerves. Asterisk denotes nestin staining in the myotome; drg, dorsal root ganglion; cg, chain ganglion; eg, enteric ganglion; vr, ventral root; nt, neural tube. Bars, 50 m (C-H). isolated early neural crest cells. Explants cultured in glial differentiation medium developed a halo of neural crest cells within 48 h in both wt and ␣4-null embryos (comparable to explants in NCC-medium; Fig. 2 ). During subsequent culture, wt cells within the halo differentiate into a characteristic meshwork of elongated cells (Figs. 3A and 3B) . These cells uniformly express nestin and GFAP, markers characteristic for glial progenitor cells in cultures of neural crest cells (Figs. 3C and 3D; Stemple and Anderson, 1992) . However, these glial cells were lost in cultures from ␣4-null embryos and only a few cells close to the neural tube remained after 6 days (Fig. 3E) . The first sign of cell loss occurred after 3 days of culture when increasing numbers of small, phase-bright cells appeared within the outgrowth from ␣4-null explants, compared with relatively few in wt cultures. Staining for DNA fragmentation revealed many TUNEL-positive cells within the outgrowth of ␣4-null explants (Fig. 3F) including round, phase-bright cells, confirming that glial progenitor cells die by apoptosis in the absence of ␣4-integrins. Some wt cells also undergo apoptosis during differentiation into the meshwork of glial progenitor cells, although many fewer. Therefore, ␣4-integrins appear essential for survival of the glial lineage.
Characterization of the Survival Defect in Immortalized Cells
To study further the phenotype of ␣4-null cells, we made use of a method allowing glial progenitor cells derived from explants to be conditionally immortalized. We had observed that neural crest cells containing a temperaturesensitive LTAg (ts58) developed into immortalized glial cell lines when cultured under conditions used for the glial explants. The immortalized progenitor cells uniformly express nestin and GFAP, but none of the later Schwann cell differentiation markers such as S100, Krox-20, and Po (H. Haack and R. O. Hynes, unpublished results). The glial cell lines can be cultured at permissive conditions for extended periods and differentiated into Schwann cells upon shift to restrictive conditions. The temperature-sensitive LTAg from immortomouse was introduced into the ␣4-strain and glial progenitor cells from ␣4-null embryos, and wt littermates were successfully immortalized (referred to as ␣4-glimorto and wt-glimorto, respectively). LTAg is required to rescue the survival defect early during the immortalization procedure, since ␣4-null cultures without LTAg were lost between the second and the third passage.
We used the ␣4-glimorto cell lines to characterize the apoptotic phenotype in vitro. Differentiation induces changes in cell morphology within 24 h and the loss of ␣4-glimorto cultures within 6 days of culture, comparable to the results with primary cells (data not shown). However, the loss of ␣4-null cells was found to be cell-densitydependent. Immortalized cells were induced to differentiate at subconfluent density and then replated at high or low cell density. Null cells plated at low density, allowing practically no cell-cell contacts, became rounded and phase bright and were gradually lost (Figs. 4A and 4B ). ␣4-glimorto cells plated at high density, allowing for cell-cell contacts, survived and grew to confluency instead, similar to wtglimorto cells (Figs. 4C and 4D ). Density-dependent effects were observed even in the same culture plate, for example when high cell density was restricted to the center of the plate, pointing to cell-cell contacts rather than secreted survival factors in the medium as the crucial rescuing factor. The cell-density-dependent survival was confirmed in primary ␣4-null cells, obtained from 2-to 3-day-old explants. The phenotype of ␣4-null cells persisted when plated on other extracellular matrices, including vitronectin and laminin. Interestingly, null cells initially adhered and spread on all matrices and showed some motility within the first 2 h after plating, as confirmed by time-lapse videomicroscopy (data not shown). Subsequently, many null cells became immotile and within a short time period displayed a rounded and phase-bright morphology followed by the development of microspikes, typical of apoptotic cell death in vitro (Collins et al., 1997) . The sequence of events makes it less likely that the survival defect is due to loss of cell attachment to the substrate and favors a direct requirement for integrin ␣4-mediated survival signals. Interestingly, preliminary evidence suggests that neuregulin is not involved in the ␣4-dependent survival phenotype. Neuregulin (rHRG, ␤-1) was included during the immortalization procedure to improve the survival of ␣4-null cells. However, addition of neuregulin further reduced survival and resulted in complete loss of cells within one passage (data not shown). This is probably caused by accelerated differentiation of neural crest cells into glial progenitor cells that become dependent on ␣4 for survival. Likewise, neuregulin did not rescue the survival defect of an established ␣4-null glial cell line cultured under restrictive conditions (data not shown).
Glial differentiation does not seem to require ␣4, since primary and immortalized ␣4-null cells were able to differentiate into highly elongated, mature Schwann cells expressing Po when plated at high density (Fig. 4E) . In addition, ␣4-deficient cells can be seen to upregulate the Schwann cell differentiation marker S100 in glial explants when in close contact with axons (Fig. 4F) . Outgrowth of axons and high cell density to rescue ␣4-null cells can be achieved when large neural tube fragments are used for glial explants. Glial progenitor cells apparently do not require ␣4 for differentiation into Schwann cells, but are dependent on ␣4 for survival when cells are not in close contact.
Survival of Migratory ␣4-Null Cells Is Compromised in Chicken Chimeras
We have recently developed a system to study cell migration within an embryonic in vivo context using immortalized mouse cell lines obtained from embryos. Cells established in vitro are grafted into the migratory pathway of the early chicken embryo. Comparing wt with genetically altered cells can assess the degree of migration, choice of pathway, and contribution to the PNS. In this study we analyzed integrin-deficient cells obtained from embryos, but the system can also be used to assess cell migration following manipulation in vitro, for example in cells containing retrovirally expressed transgenes (to be described in detail elsewhere). We used the grafting assay to investigate whether the cell-density-dependent survival defect of ␣4-
FIG. 4. ␣4-null cells can differentiate into
Schwann cells when cultured at high cell density. Shown are phase-contrast images of immortalized glial progenitor cells from wt (A, C) or ␣4-null (B, D) cultures 24 h after they were seeded at low density (A, B) or at density allowing cell-cell contacts (C, D). Null cells are lost when cultured at low density and many small, round, and phase-bright cells are present (B). ␣4-null progenitor cells can differentiate into Schwann cells expressing the terminal differentiation marker Po in long-term cultures when seeded at high density (E). High cell density can also be achieved using larger explants (12-15 somites). Axons grow out from the neuroepithelium under these conditions (labeled in red with NF160; black arrow) and ␣4-null glial cells next to the axons or in close proximity upregulate the glial differentiation marker S100 (F; green). Bars, 200 m (A-D), 100 m (E, F).
null cells persists in vivo and whether cell migration can occur normally within the context of an embryonic environment. Immortalized cells were shifted to restrictive conditions for 1-2 days to allow inactivation of LTAg and used as graft material. About 50 -100 cells were transplanted into chicken embryos adjacent to the neural tube and the emerging endogenous neural crest cells. Wt cells (clone 115-2), labeled with DiI, migrate extensively along the ventral and ventrolateral migratory pathway (adjacent to the dermamyotome) and contribute to DRG and Schwann cells lining the peripheral nerves (Figs. 5A and  5C ). Contribution from ␣4-null cells (clone 415-3) was clearly reduced (n ϭ 14 grafts) after 2 days of development compared to wt cells (n ϭ 10); this difference is clearly visible in fluorescent images of whole-mount embryos (Figs. 5A and 5B). Further sectioning showed that the difference in labeling intensity is mostly due to a reduction of null cells ventrolaterally under the myotome and, dorsally, next to the neural tube near where the graft was placed initially (Figs. 5C and 5D ). However, null cells were present in DRG and along peripheral nerves even after 4 days of development (Figs. 5E and 5F), although the number of null cells in the DRG was only a third of that in wt controls (wt, 240 Ϯ 7.7 cells; null, 86 Ϯ 43 cells). The results were confirmed using an independently derived null clone (415-6), which was more severely affected in vitro and resulted in correspondingly fewer surviving null cells after grafting into embryos. Therefore, ␣4-null cells can migrate and contribute to the PNS. However, there is some loss of cells, especially dorsally. Investigation of earlier time points showed that the survival of null cells is already compromised during their early migration. Null cells initially migrate away from the graft (12 h), as shown in Fig.  6B , but have not expanded as far into the surrounding tissues as have wt grafts (Fig. 6A) . A few hours later (18 -24 h) fewer cells were visible in null transplants compared with wt (Figs. 6C and 6D; 11/11 ␣4-null, 9 wt), suggesting elimination of null cells by apoptosis early during migration. Dye exclusion labeling using Nile blue was used to visualize the pattern of cell death (Figs. 6E-6G ). Cells that had died and taken up the dye were seen at the graft site 12-14 h following transplantation in null (n ϭ 7) but not wt (n ϭ 5) transplants. Most Nile blue-positive cells were located proximal and dorsal to the remaining DiI-labeled cells (Fig. 6G ). Significant numbers of Nile blue-positive cells were not observed at the graft site at later stages (18 -36 h), suggesting that cell death occurs mostly during the early migratory phase. In contrast to the dorsal pathway, null cells that migrate along the ventral pathway were not obviously reduced during early migration (Fig. 6H) . Null cells migrate along the ventral pathway in a continuous stream of cells (Fig. 6H) . Perhaps a higher cell density, which protected ␣4-null cells against apoptosis in vitro (see Fig. 4 ), improves survival of null cells in the ventral pathway. Thus, ␣4-integrins seem to be required to protect cells from apoptosis during cell migration.
␣4-Integrin Deficiency Does Not Lead to Upregulation in the Surface Expression of Other Integrins
Our results suggest that ␣4-integrins are not required for the migration of neural crest cells or for cell motility of neural crest-derived glial progenitor cells. Since this is in contrast to previous studies (Kil et al., 1998) , we tested the possibility that changes in the surface expression of other integrins might be compensating for ␣4 during migration. Pools of either wt-glimorto or ␣4-glimorto cells were surface biotinylated and immunoprecipitated with antibodies against integrins previously shown to promote neural crest migration (Desban and Duband, 1997; Lallier et al., 1994; Testaz et al., 1999) . Cells were analyzed using conditions promoting cell motility in vitro. ␤1 and ␤3 and the ␣ subunits ␣3, ␣5 and ␣v are present in these cells (Fig. 7) . The pattern of ␣ and ␤ bands suggests expression of integrins ␣1␤1, ␣3␤1, ␣5␤1, and low levels of ␣v␤3 on the cell surface. In addition, ␣v heterodimers other than ␤3 are present, most likely ␤1 but perhaps also ␤5, ␤6, and ␤8, which migrate at a similar kilodalton range in nonreducing SDS-PAGE. There was no increase in surface expression of these integrins in ␣4-null cells compared to wt. In fact, integrin expression levels are somewhat reduced in ␣4-null cells with the exception of ␣3␤1. The reduced surface expression is likely due to differences in cell morphology, since ␣4-null cells do not spread as well and contain fewer filopodial extensions than wt cells, effectively reducing the number of integrin-containing cell-matrix contacts (data not shown). Thus, ␣4-deficient cells do not show substantial upregulation in surface expression of integrins, such as ␣v␤3, ␣3␤1, and other ␤1-or ␣v-containing integrins shown to promote neural crest migration in vitro. The discrepancies with previous studies regarding the role of ␣4 in cell migration remain to be explained (see Discussion).
Emigration of ␣5-Null Neural Crest Cells Is Deficient in Neural Tube Explants
␣5-null embryos die during the migratory phase of neural crest development, allowing study of the early migratory phase of cranial neural crest cells, but not the migration and subsequent differentiation of truncal neural crest cells (Goh et al., 1997; Yang et al., 1993) . We have therefore investigated the ability of neural crest cells to migrate in the absence of ␣5-integrins using neural tube explants. Because ␣5-null embryos are defective in posterior mesoderm formation it was necessary to explant neural tube fragments corresponding to the anteriormost eight somites; these give rise to both cardiac and truncal neural crest in vivo. Neural tubes from ␣5-null embryos did not attach well to FNcoated surfaces. Some neural tubes were still floating in the medium after 24 h and often showed tissue disintegration even after they attached. ␣5-null neural tubes that did attach within the first 12 h of culture had fewer emigrating neural crest cells compared to wt and the cells remained close to the neural epithelium (Figs. 8A and 8B ). ␣5-null cells did eventually migrate away from the neural tube and formed a halo of neural crest cells around the neuroepithelium similar to wild-type explants, but reduced in size (Figs.  8C and 8D) . The average diameter of ␣5-null explants was 40 -50% of the diameter of wt explants (Fig. 8G ). In contrast, on VN as substrate, neural tubes attached and neural crest emigration was not delayed (Figs. 8E and 8F ), demonstrating that null explants can develop normally and are not compromised due to early embryonic lethality.
␣5-Null Cells Can Migrate and Contribute to the PNS When Transplanted into Chicken Embryos
Previous studies have suggested that ␣5␤1 could be one of the integrins that mediate the extensive migratory ability of neural crest cells on FN as substrate. Neural crest explants are smaller in the absence of ␣5, but this could be due to the delayed attachment of neural tubes and does not address migration of neural crest cells themselves. We used the chicken transplant system to address the migratory ability of ␣5-null cells. This system requires about 50 -100 cells/ graft and thus allows cell migration to be studied when few cells are available. Primary neural crest cells, obtained from explants cultured on FN/VN, were transplanted into chicken embryos. Grafts of ␣5-null cells showed a very similar pattern of DiI signal compared to wt when inspected in whole-mount embryos 24 -48 h after grafting (total of n ϭ 23; Figs. 9A and 9B). Sectioning confirmed that migration and survival of ␣5-null cells is largely normal. The majority of the grafted cells migrated along the ventral and ventrolateral pathway and eventually integrated into the ganglia and nerves of the PNS. Both wt and null cells contributed well to the DRG and were present even after 6 days ( Figs. 9C and 9D ). However, while wt grafts all (6/6) contributed to the ventral roots and were seen along peripheral nerves emanating from the DRG, only 4/9 of the ␣5-null grafts showed significant contribution to peripheral nerves. This suggests some defect in the differentiation of ␣5-null cells along the glial lineage. In conclusion, the grafting experiments provide evidence that neural crest cells from ␣5-null embryos can migrate in vivo similarly to wt cells.
Absence of ␣5-Integrin Causes Reduced Proliferation of Glial Cells and Prevents Their Immortalization
Reduced contribution to the peripheral nerves pointed to a potential role of ␣5 in the transition from neural crest into Schwann cells. The development of neural crest cells along the glial lineage was studied in explants cultured on FN/VN to allow neural tube attachment in the absence of ␣5. We noted a reduced number of elongated glial progenitor cells in the peripheral halo around the neuroepithelium in ␣5-null explants compared to wt (data not shown). To investigate directly the ability of neural crest cells to form mature Schwann cells, neural crest cells were plated on FN under differentiation conditions. When cultured for long periods in medium containing serum and forskolin, paralleloriented and elongated Schwann cells developed in wt cultures (Fig. 10A) . ␣5-null cells gave rise to Schwann cells, as confirmed by Po expression, but were much reduced in numbers (Figs. 10B and 10C ). An epithelial cell type was present in null cultures instead but was not characterized further. To generate a sufficient number of glial progenitor cells for further study, we isolated ␣5-null cells containing the temperature-sensitive LTAg from immortomouse. Repeated attempts to generate immortalized lines from ␣5-null embryos all failed (n ϭ 5), whereas heterozygous and wt lines could be established in all cases. Different matrices (VN, FN/VN, LN) were tested but none could overcome the inability to immortalize ␣5-null cells. ␣5-null cells were present over the period of several passages but did not expand in numbers, suggesting a cell proliferation defect. Since few cells are available from ␣5-null embryos, we sought to determine proliferation rates and survival in primary cells seeded at clonal density. Neural crest cells were replated from explants and cultured in glial proliferation medium. ␣5-deficient clones proliferated very little even in the presence of LTAg (Fig. 11A) . The number of cells per clone after 4 days was reduced to 34% in ␣5-null clones and 21% in ␣5-null/LTAg clones, compared to their wt counterparts. The survival of ␣5-null cells was not much affected at this stage; 91% of the ␣5-null clones were still present after 4 days (Fig. 11B) . However, many ␣5-null clones contained only one or two cells/clone during the first 4 days of culture, suggesting that proliferation rather than survival causes the reduced growth of ␣5-null cells. Survival was significantly reduced toward the end of culture and included all one-or two-cell clones, indicating the loss of dormant, nonproliferating ␣5-null cells. LTAg did not rescue proliferation (Fig. 11A ) or clone survival (Fig. 11B ) and only 3% of the cells in wt/LTAg clones were present in ␣5-null/LTAg clones at the end of culture.
DISCUSSION
The regulation of glial cell numbers is an important component of nerve development and regeneration and is involved in many disease processes of the PNS. Glial growth factors, localized on axonal membranes or secreted by macrophages or Schwann cells themselves, have been shown to be major contributors to the regulation of glial cell numbers . In the present study, we analyzed the roles that ␣4 and ␣5 may play during neural crest development and report significant defects in proliferation and survival of glial progenitor cells in the absence of these integrins. Using explant assays to study glial development in vitro we found that both integrins are required for the growth of glial progenitor cells. Each integrin regulates a different aspect of glial growth with little apparent overlap in their function. ␣5 is mostly required for proliferation and ␣4 is necessary for survival in vitro or after grafting into chicken embryos in ovo. Thus, integrin-mediated cell-cell or cell-matrix interactions appear to be important for the regulation of glial cell numbers.
Schwann cells express several integrins during nerve development and these have been associated with migration and differentiation into myelinating cells (FernandezValle et al., 1994; Milner et al., 1997) . While cell-matrix interactions are known to affect the growth of Schwann cells (Bunge et al., 1989) , integrin receptor-mediated signaling has not yet been demonstrated. The integrins ␣4 and ␣5 do not appear to be individually essential for glial differentiation since null cells can develop into mature Po-positive Schwann cells in explants. The presence of ␣5 and FN (Lefcort et al., 1992) and ␣4 (Sheppard et al., 1994) during embryonic and postnatal nerve development is therefore likely to reflect integrin-mediated regulation of Schwann cell numbers and/or migration rather than differentiation. Analysis in embryonic explants showed that growth regulation by ␣4 and ␣5 is required during the early stages of glial development, consistent with their expression during early nerve development in vivo. For example, ␣4-null cells die after a few days in culture, during the transition from neural crest to elongated, bipolar Schwann cells. The expression of markers characteristic for neural crest-derived glial progenitor cells and the differentiation into Popositive, elongated cells clearly identifies the primary and immortalized cells as progenitor cells of the peripheral glial lineage. However, we do not know at present the exact nature of these cells. They probably represent an intermediate stage between neural crest cells and Schwann cell precursors, the earliest cell type of the Schwann cell lineage found in embryonic nerves. Schwann cell precursors readily undergo apoptosis in the absence of survival factors and are characterized by expression of GAP-43 and Krox-24 and absence of Krox-20 and S-100 (Dong et al., 1999; Jessen et al., 1994) . Interestingly, the glial progenitor cells that we were able to immortalize also express GAP-43 and Krox-24, but differ from Schwann cell precursors found in nerves in both morphology and response to glial growth factors (H. Haack and R. O. Hynes, unpublished results) .
The development of embryonic nerves requires extensive migration of Schwann cells to accompany the outgrowing axons. Many glial cells have to be generated during this process and their numbers have to be matched to nerve fiber numbers and ganglia size, which differ along the anteroposterior body axis. It is therefore not surprising that survival and proliferation of Schwann cells is controlled in a dynamic fashion during embryogenesis (Ciutat et al., 1996; Stewart et al., 1993) . This ensures that Schwann cells are generated or eliminated at specific times and locations during peripheral nerve development. Trophic support provides one regulatory component of the time-and place-specific control of Schwann cell numbers. The phenotype of ␣4-and ␣5-deficient cells suggests that the extensive and dynamic regulation of Schwann cell numbers involves further refinement by integrin-mediated cell-matrix signaling.
FIG. 7.
Surface expression of integrins from wild-type and ␣4-null glial progenitor cells. Detergent lysates from immortalized cell pools of wt (ϩ) and ␣4-null (Ϫ) lines were surface biotinylated and immunoprecipitated with antisera against integrin subunits; indicated on top of each lane. The neural crest-derived progenitor cells express the ␤1 (migrates as 110-kDa band in nonreducing SDS-PAGE), ␤3 (90 kDa), ␣3 (150 kDa), ␣5 (155 kDa), and ␣v subunits (150 kDa). Immunoprecipitations with ␤1 antisera also precipitate a higher molecular weight species, probably ␣1 (200 kDa). There is no compensatory upregulation of these integrins in ␣4-null cells. Rather, surface expression levels appear reduced compared to wt, with the exception of ␣3. Migratory positions of ␣ and ␤ subunits are indicated to the left. Positions for 179-, 115-, and 83-kDa molecular weight markers are shown to the right. Samples were resolved by SDS-PAGE on 8% acrylamide gels under nonreducing conditions and biotinylated bands visualized with streptavidinhorseradish-peroxidase and chemiluminescence. Rabbit IgG (rb IgG) was used as control. (C, D) . ␣5-null explants (F) are not delayed on VN as substrate, compared with wt (E). The average diameter of ␣5-null explants is clearly reduced during the culture period (G). Explant sizes are determined and presented as described in Fig. 2 . Note that the explant diameter does not reflect neural crest migration in this case, because neural tube attachment and spreading are delayed in ␣5-null explants; ne, neural epithelium. Bars, 250 m (A-F).
The reduced proliferation rate in clonal culture and the reduced number of mature Schwann cells in culture show that ␣5 is required for efficient proliferation of glial progenitor cells. In addition, the inability of LTAg to rescue ␣5-null cells is a strong indication that cell-matrix interactions are crucial. The expression profile of FN and ␣5 correlates well with phases of proliferation in developing nerves and during nerve regeneration, in which both FN and ␣5 are upregulated at the site of injury (Lefcort et al., 1992; Peters and Hynes, 1996) . FN is strongly mitogenic when added to the culture medium (Baron-Van Evercooren et al., 1982) and is specifically upregulated during the transition from slowly to rapidly dividing cells (Eccleston et al., 1991) . Thus, FN appears to be important for glial proliferation, likely to be mediated by integrins. Based on the strong proliferative defect of ␣5-deficient cells, we suggest that ␣5␤1 is the predominant receptor transmitting FN-mediated growth stimuli in Schwann cells. ␣5␤1 has been associated with proliferation in a number of other cell types (Lundell et al., 1996; Sastry et al., 1996; Varner et al., 1995) although the signaling pathways remain incompletely understood.
We have shown that ␣4-integrin contributes to the survival of glial progenitor cells, both in primary explant cultures and after transplantation into the chicken embryo. Whether ␣4 is required for survival during nerve development in vivo is not clear. The expression of glial markers suggests that glial cells are present in normal numbers in ␣4-null embryos. However, glial proliferation and apoptosis occur during most of peripheral nerve development and are only just beginning when ␣4-null embryos die. In addition, it is likely that defects in vivo will be limited to a particular cell population, since the survival requirement for ␣4 is clearly cell-density dependent. The observation that high cell density can rescue ␣4-null cells from apoptosis is probably of importance in vivo, but we do not yet know its relevance for nerve development. It is likely that the rescue is due to the formation of cell-cell contacts, since the media, growth factors, and ECM substrates that were tried could not rescue the ␣4-null phenotype. Interestingly, we have observed that glial progenitor cells form long, thin filopodia in culture that extend over several cell diameters and connect with their neighboring cells (unpublished observations). It is conceivable that cell communication established through the filopodial contacts is involved in the control of cell survival. The absence of cell-cell contacts could also explain the results during cell migration in ovo. Migration along the ventral neural crest pathway allows ␣4-null cells to survive and contribute to the PNS. Cells in the ventral pathway migrate as a stream of closely connected cells that allows extensive cell-cell contact between the transplanted glial progenitor cells and the endogenous neural crest cells. Migration along the dorsolateral neural crest route does not promote survival, perhaps because cell contacts are limited during migration through these pathways or because interaction occurs with cell types or ECM that cannot rescue apoptosis in ␣4-null cells.
␣4 is distinct from most other integrins due to its expression in highly migratory cell types, including melanocytes, leukocytes, and Schwann cells (Sheppard et al., 1994) . In addition, migration can be disturbed with blocking reagents against ␣4 (Kil et al., 1998) . Thus available evidence suggests that ␣4 participates in cell motility, perhaps by mediating connections between the cytoskeleton, the motility machinery, and cell-substrate contacts. Our results confirm a role for ␣4 during migration, but they suggest that survival rather than cell motility is regulated by ␣4, at least in glial progenitor cells. There are several in vivo contexts in which ␣4-integrins might be required for the survival of migratory cell populations. They promote survival in the B cell lineage and have been suggested to contribute to B cell selection in vivo (Koopman et al., 1994) .
Analyses of mouse chimeras have demonstrated that ␣4-deficient lymphocytes and other blood cells are lost gradually during maturation of the hematopoietic system (Arroyo et al., 1996 (Arroyo et al., , 1999 . Finally, ␣4-integrins play important roles during various steps of metastasis in animal models (reviewed in Holzmann et al., 1998) . Though not directly linked, the suppression of metastasis in ␣4-expressing LB T-cell lymphoma, for example, has been suggested to involve regulation of programmed cell death Gosslar et al., 1996) . It is tempting to speculate that survival signals derived from ␣4 -ligand interactions serve as a safeguard mechanism during migration to eliminate cells that have invaded inappropriate tissue compartments. We initiated analysis of ␣4 and ␣5 in the highly migratory neural crest cells because integrins are thought to be important for their motility and development. However, our results suggest that neural crest cells are capable of largely normal migration in the absence of either one of these integrins. This is particularly surprising for ␣4, since a crucial role in neural crest migration has recently been suggested for this integrin using function-blocking approaches (Kil et al., 1998) . The peripheral nervous system and the expression of various markers for neural crest-derived cells were analyzed in detail in ␣4-null embryos, but abnormalities were not apparent, even during early stages of development (Fig. 1) . A severe defect in crest migration is therefore not very likely. Furthermore, the absence of ␣4 did not interfere with neural crest migration on a fibronectin substrate in explant cultures (Fig.  2) . Thus, it seems safe to conclude that ␣4 is not essential for neural crest migration in vivo or in vitro. ␣4-null glial progenitor cells are also capable of extensive migration in the in vivo migration assay (Fig. 5) , while their survival was clearly compromised. These cells are not equivalent to early neural crest cells, but the observation further suggests that loss of ␣4 does not necessarily interfere with cell migration along neural crest pathways. Our results are consistent with studies of neural crest cells as well as rat neonatal Schwann cells in vitro, indicating that ␣4 and ␣5 seem less important for cell migration than, for example, ␣v-integrins (Milner et al., 1997; Testaz et al., 1999) . As has been observed with other loss-offunction phenotypes, integrin-deficient cells often show less severe phenotypes than had been expected based on earlier data. In some cases this has been shown to involve compen-sation by other integrins (discussed in Hynes, 1996) . For example, ␣v can functionally compensate for ␣5 during adherence and spreading of null fibroblasts . ␣4-deficient cells did not show upregulation of ␤1-or ␤3-integrins previously implicated in truncal neural crest migration (Desban and Duband, 1997; Lallier et al., 1994; Testaz et al., 1999) , although it remains possible that upregulation occurs in vivo. However, compensation through overlapping functions of integrins even without clear changes in surface expression levels remains a possibility, given that neural crest cells express more than 11 distinct integrins (Testaz et al., 1999) . In addition, none of the loss-of-function studies in the mouse have confirmed a crucial role for integrin ␣-chainmediated cell migration with the exception of ␣3-mediated neuronal migration (discussed in Anton et al., 1999; Hynes, 1996) . Likewise, extensive migration of neural crest cells occurs in the absence of all ␤1-integrins (Fassler and Meyer, 1995) , pointing to the possibility of overlapping functions of integrins during the migratory process.
In order to facilitate the analysis of neural crest cells from the early embryonic lethal integrin mutants, a number of novel experimental assays were developed. We believe these provide useful tools to study Schwann cell development and cell migration in vivo. Immortalized glial progenitor cells can be readily derived from early mouse embryos to take advantage of genetically manipulated mice, including most embryonic lethal mutants. Both primary and immortalized cells express markers for glial progenitor cells, have similar morphology and growth requirements, and can be differentiated into mature Schwann cells in vitro. Thus, glial cells derived by immortalization appear to resemble primary glial progenitor cells closely. Since immortalization is conditional, large cell numbers can be generated while experiments can be performed in the nonimmortalized state, allowing various differentiation stages to be analyzed. Finally, the cells can be grafted into chicken embryos to follow migration and perhaps even early differentiation, although it is not clear yet whether the grafted cells can adopt normal physiological functions in this context. The in ovo migration assay was primarily devised to allow the study of cell migration in vivo using cells that are characterized and accessible to manipulation in vitro. The results obtained for ␣4 clearly demonstrated that grafting of mouse cells into chicken embryos can reveal important aspects of cellular behavior during migration. Several aspects of cell migration, such as distance of migration and choice of migratory pathway, can also be studied in the in ovo migration assay (H. Haack and R. O. Hynes, unpublished studies).
Integrins have been shown here to contribute to the control of glial cell numbers. They are likely to do so in the context of a developing nerve or perhaps even during nerve regeneration. We suggest that the time-and place-specific generation or elimination of glial cells during PNS development involves a combination of growth factor and integrinmediated signaling.
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